Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVOLVE: Peri-operative acetylsalicylic acid for stroke prevention after coiling of unruptured brain aneurysms
2024-517674-23-00Phase 3Authorised
- Sponsor
- University of Calgary
- Start
- May 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in brain aneurysm (IA) and ischemic stroke comparing Aspirin (Salospir) with Placebo (2 arms). Primary endpoint: Incidence of embolic strokes on Day 5. Planned start May 2023; status: authorised.
02
Drugs
aspirin
03
Conditions
brain aneurysm (IA)ischemic stroke
Beyond the preview
Go deeper on 2024-517674-23-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517674-23-00.